HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC

Name: HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC
License: Public Domain

West China Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

urinary bladder neoplasms

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 668810
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.